Nalpropion Pharmaceuticals v. Actavis Laboratories FL, Inc.

 
APPEAL NO.
18-1221
OP. BELOW
DCT
SUBJECT
Patent
AUTHOR
Lourie

Question(s) Presented

“To comply with the written-description requirement, must the specification describe ‘the invention, with all its claimed limitations,’ not just ‘that which makes it obvious,’ as this Court has long held? . . . Or for some claim limitations, can the specification merely disclose a ‘substantially equivalent’ method step, as the panel majority concluded here?”

Posts About this Case